{
    "2019-03-25": [
        [
            {
                "time": "",
                "original_text": "国泰君安(02611.HK)控股股东及一致行动人减持700万张A股可转债 减持股份",
                "features": {
                    "keywords": [
                        "国泰君安",
                        "控股股东",
                        "一致行动人",
                        "减持",
                        "可转债"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "国泰君安：控股股东及一致行动人合计减持可转债700万张，占发行总量的10%",
                "features": {
                    "keywords": [
                        "国泰君安",
                        "控股股东",
                        "一致行动人",
                        "减持",
                        "可转债",
                        "发行总量"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "108股获券商买入评级 天康生物目标涨幅达71.88%",
                "features": {
                    "keywords": [
                        "券商",
                        "买入评级",
                        "天康生物",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "农业",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}